|
⚲
|
| Keyboard |
| Ziebell Mark R
✚
|
|
|---|---|
| CIK # | 0001552642 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001552642] | |
| 4 | [0001552642] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Peregrine Pharmaceuticals Inc | |
| Ziebell Mark R |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2025-02-05 | Disposed to issuer | 66,799 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 14,286 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 108,579 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 1,733 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 17,679 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2025-02-05 | Disposed to issuer | 51,413 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 55,310 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 98,120 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Stock Option (right to buy) · derivative
|
2025-02-05 | Disposed to issuer | 21,429 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-07-09 | Option exercise | 34,226 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Performance Stock Units · derivative
|
2024-07-09 | Option exercise | 68,452 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-06-28 | Other | 1,965 | $5.41 | 10,631 |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-04-30 | Sell | 1,643 | $7.40 | 12,158 |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-04-09 | Option exercise | 1,261 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-04-09 | Option exercise | 1,251 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-04-09 | Option exercise | 1,251 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-04-09 | Option exercise | 1,261 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-04-09 | Option exercise | 696 | ||
|
Peregrine Pharmaceuticals Inc CDMO
Restricted Stock Units · derivative
|
2024-04-09 | Option exercise | 696 | $0.00 | |
|
Peregrine Pharmaceuticals Inc CDMO
Common Stock, $0.001 par value
|
2024-01-10 | Sell | 1,346 | $6.17 | 8,305 |
| showing 20 of 139 most recent transactions | |||||